United Therapeutics (UTHR) Other Non Operating Income (2009 - 2026)

United Therapeutics has disclosed Other Non Operating Income across 18 years of filings, most recently posting -$46.3 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$46.3 million, down 976.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.9 million (up 2400.0% YoY), and the FY2025 annual result was $48.9 million, up 743.1% from the prior year.
• Other Non Operating Income came in at -$46.3 million for Q1 2026 at United Therapeutics, down from $47.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $47.2 million in Q4 2025 to a low of -$51.8 million in Q2 2022.
• The 5-year median for Other Non Operating Income is -$600000.0 (2023), against an average of -$2.7 million.
• Across the five-year window, Other Non Operating Income tumbled 1818.52% in 2022 and soared 1915.38% in 2025, its largest moves.
• United Therapeutics' Other Non Operating Income stood at -$5.3 million in 2022, then surged by 88.68% to -$600000.0 in 2023, then plunged by 333.33% to -$2.6 million in 2024, then jumped by 1915.38% to $47.2 million in 2025, then sank by 198.09% to -$46.3 million in 2026.
• The last three Other Non Operating Income figures came in at -$46.3 million (Q1 2026), $47.2 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.